These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


307 related items for PubMed ID: 15504707

  • 1. DNA vaccines and their application against parasites--promise, limitations and potential solutions.
    Smooker PM, Rainczuk A, Kennedy N, Spithill TW.
    Biotechnol Annu Rev; 2004; 10():189-236. PubMed ID: 15504707
    [Abstract] [Full Text] [Related]

  • 2. DNA vaccines against tropical parasitic diseases.
    Da'dara AA, Harn DA.
    Expert Rev Vaccines; 2005 Aug; 4(4):575-89. PubMed ID: 16117713
    [Abstract] [Full Text] [Related]

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 4. [The new generations of vaccines against parasites].
    Wedrychowicz H.
    Wiad Parazytol; 2000 Dec; 46(1):21-7. PubMed ID: 16886350
    [Abstract] [Full Text] [Related]

  • 5. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.
    Zimmermann S, Dalpke A, Heeg K.
    Int J Med Microbiol; 2008 Jan; 298(1-2):39-44. PubMed ID: 17716944
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A, Ojeda A, López-Fuertes L, Timón M, Altet L, Solano-Gallego L, Sánchez-Robert E, Francino O, Alberola J.
    Vaccine; 2007 Nov 14; 25(46):7962-71. PubMed ID: 17942199
    [Abstract] [Full Text] [Related]

  • 7. DNA vaccines: a rational design against parasitic diseases.
    Carvalho JA, Rodgers J, Atouguia J, Prazeres DM, Monteiro GA.
    Expert Rev Vaccines; 2010 Feb 14; 9(2):175-91. PubMed ID: 20109028
    [Abstract] [Full Text] [Related]

  • 8. [Challenge of developing anti-parasite vaccines in the tropics].
    Rogier C.
    Med Trop (Mars); 2007 Aug 14; 67(4):328-34. PubMed ID: 17926789
    [Abstract] [Full Text] [Related]

  • 9. Optimization and delivery of plasmid DNA for vaccination.
    Jechlinger W.
    Expert Rev Vaccines; 2006 Dec 14; 5(6):803-25. PubMed ID: 17184219
    [Abstract] [Full Text] [Related]

  • 10. DNA vaccination against pseudorabies virus and bovine respiratory syncytial virus infections of young animals in the face of maternally derived immunity.
    Hamers C, Juillard V, Fischer L.
    J Comp Pathol; 2007 Jul 14; 137 Suppl 1():S35-41. PubMed ID: 17553517
    [Abstract] [Full Text] [Related]

  • 11. Expression library immunization to discover and improve vaccine antigens.
    Barry MA, Howell DP, Andersson HA, Chen JL, Singh RA.
    Immunol Rev; 2004 Jun 14; 199():68-83. PubMed ID: 15233727
    [Abstract] [Full Text] [Related]

  • 12. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A, Zahedifard F, Taghikhani M, Rafati S.
    Vaccine; 2008 Jun 19; 26(26):3362-70. PubMed ID: 18471945
    [Abstract] [Full Text] [Related]

  • 13. The evolution of DNA vaccines.
    Apostolopoulos V, Plebanski M.
    Curr Opin Mol Ther; 2000 Aug 19; 2(4):441-7. PubMed ID: 11249775
    [Abstract] [Full Text] [Related]

  • 14. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.
    Babiuk S, Tsang C, van Drunen Littel-van den Hurk S, Babiuk LA, Griebel PJ.
    Bioelectrochemistry; 2007 May 19; 70(2):269-74. PubMed ID: 17118714
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.
    Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672
    [Abstract] [Full Text] [Related]

  • 16. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR, Letvin NL.
    Vaccine; 2007 May 10; 25(19):3731-41. PubMed ID: 17350735
    [Abstract] [Full Text] [Related]

  • 17. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
    Kennedy NJ, Spithill TW, Tennent J, Wood PR, Piedrafita D.
    Vaccine; 2006 Feb 13; 24(7):970-9. PubMed ID: 16242220
    [Abstract] [Full Text] [Related]

  • 18. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C.
    Vaccine; 2009 Jan 01; 27(1):99-106. PubMed ID: 18951941
    [Abstract] [Full Text] [Related]

  • 19. [Progress of research on DNA vaccines against parasitosis].
    Qi WJ, Fang Q.
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun 01; 23(3):340-4. PubMed ID: 22164511
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D, Wang S, Cai W, Du A.
    Vaccine; 2008 Aug 18; 26(35):4541-8. PubMed ID: 18590785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.